This site is intended for healthcare professionals
Drug news

European Commission approval for Isturisa for the treatment of people with endogenous Cushing's syndrome.- Recordati

Read time: 1 mins
Last updated:19th Jan 2020
Published:19th Jan 2020
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest